Table 1 Demographic details and PASI scores for patients used to develop genomic classifier to alefacept.
Patients | Age | Gender | Ethnicity | Response | PASI Baseline | PASI End of treatment |
|---|---|---|---|---|---|---|
1 | 33 | M | Caucasian | NR | 6.1 | 4.3 |
2 | 52 | M | Caucasian | NR | 6.8 | 5.3 |
3 | 49 | M | Hispanic | NR | 23.0 | 19.4 |
4 | 59 | M | Caucasian | NR | 43.2 | 32.2 |
5 | 59 | M | Caucasian | NR | 17.7 | *NA |
6 | 55 | M | Caucasian | NR | 34.3 | 22.8 |
7 | 38 | M | Caucasian | NR | 9.3 | 4.7 |
8 | 49 | M | Caucasian | R | 10.9 | 2.7 |
9 | 43 | M | Caucasian | R | 26.1 | 19.3 |
10 | 45 | M | African American | R | 17.1 | 2.2 |
11 | 36 | M | Asian | R | 17.1 | 2.3 |
12 | 44 | M | Hispanic | R | 35.0 | 5.2 |
13 | 41 | M | Caucasian | R | 20.7 | 5.9 |
14 | 68 | M | Caucasian | R | 17.1 | 14.4 |
15 | 62 | M | Caucasian | R | 9.4 | 3.8 |
16 | 29 | F | Hispanic | R | 16.8 | 2.0 |